Alzheimer's Disease
M Ventures led the round with participation from Grey Sky Venture Partners, VI Partners AGG, Alpana Ventures and FYRFLY Ventures.
The Montreal-based company uses spectral retinal imaging technology and AI to deliver a cheaper alternative to early Alzheimer's disease detection.
As laid out in the 21st Century Cures Act, the Breakthrough Devices Program looks to streamline new medical technologies that offer improved treatment for serious diseases.
Dementia-focused tech company Smart Brain Aging has announced the launch its virtual offering for the aging population.